SEC Form 4 · accession 0001209191-15-001362
Tobira Therapeutics, Inc. · TBRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
R Don Elsey
Officer — Sr. VP/Chief Financial Officer
Period of report
Jan 1, 2015
Accepted (ET)
Jan 5, 2015 · 6:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001311596
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock (right to buy)F1 | $0.91 | Jan 1, 2015 | A | 92,902 | A | — | Dec 31, 2024 | Common Stock | 92,902 | 92,902 | D |
Explanation of responses
- F123,225 shares subject to the option shall vest on the one year anniversarity of the date of grant. The remainder of the shares vest and become exerciseable in 36 equal monthly installments over 3 years beginning on the one year anniversary of the grant date subject to the executive's continued service